A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome

Por um escritor misterioso
Last updated 16 março 2025
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
medRxiv - The Preprint Server for Health Sciences
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Advances in mechanical biomarkers - Eroles - 2023 - Journal of Molecular Recognition - Wiley Online Library
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A Multi-omics Longitudinal Study Reveals Alteration of the Leukocyte Activation Pathway in COVID-19 Patients
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Immune response in COVID-19: what is next?
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Individual COVID‐19 disease trajectories revealed by plasma proteomics
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Longitudinal Plasma Proteomics Analysis Reveals Novel Candidate Biomarkers in Acute COVID-19
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcome
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Next-Generation Serology by Mass Spectrometry: Readout of the SARS-CoV-2 Antibody Repertoire
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Metabolomics study of COVID-19 patients in four different clinical stages
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples - eBioMedicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Multi-organ proteomic landscape of COVID-19 autopsies - ScienceDirect
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: An observational multi-cohort study - eClinicalMedicine
A time-resolved proteomic and diagnostic map characterizes COVID-19 disease  progression and predicts outcome
Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients - ScienceDirect

© 2014-2025 safaronline.com. All rights reserved.